$41.5 Million is the total value of ABG-WTT Global Life Science Capital Partners GP Ltd's 3 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | CG ONCOLOGY INC | $40,190,494 | – | 915,501 | +100.0% | 96.80% | – | |
| RAPID MICRO BIOSYSTEMS INC | $768,339 | 0.0% | 1,038,296 | 0.0% | 1.85% | +23.6% | ||
| LUNG | PULMONX CORP | $558,091 | -27.3% | 60,204 | 0.0% | 1.34% | -10.2% | |
| Exit | MEDAVAIL HOLDINGS | $0 | – | -300,588 | -100.0% | -2.63% | – | |
| Exit | RAYZEBIO INC | $0 | – | -778,922 | -100.0% | -94.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PULMONX CORP | 15 | Q2 2024 | 49.0% |
| MEDAVAIL HOLDINGS INC | 12 | Q3 2023 | 92.0% |
| RAPID MICRO BIOSYSTEMS INC | 10 | Q2 2024 | 57.2% |
| CG ONCOLOGY INC | 2 | Q2 2024 | 96.8% |
| RAYZEBIO INC | 2 | Q4 2023 | 94.4% |
| MEDAVAIL HOLDINGS | 1 | Q4 2023 | 2.6% |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.